Advertisement

Topics

Aradigm Corporation and Grifols S.A. Company Profile

06:57 EST 18th December 2018 | BioPortfolio

Aradigm is an emerging specialty pharmaceutical company focused on the development and commercialization of drugs delivered by inhalation for the prevention and treatment of severe respiratory diseases. Aradigm has product candidates addressing the treatment of bronchiectasis, cystic fibrosis, inhalation tularemia and anthrax infections, and prevention of respiratory and other diseases in tobacco smokers through smoking cessation.


News Articles [118 Associated News Articles listed on BioPortfolio]

2018 Grifols: Market Shares and Competitive Position by Product and CountryPerformance, Capabilities, Goals and Strategies in the Global Diagnostics Industry [Report Updated: 01011970] Prices from USD $3250

This unique market intelligence report from VPGMarketResearch provides information not available from any other published source. The report includes diagnostics sales and market share estimates by pr...

Grifols' post-exposure measles, hepatitis A therapy wins FDA nod

Grifols' immune globulin formulation GamaSTAN was granted approval by the FDA for protection of people who have been exposed  -More- 

FDA clears 2 blood screening assays from Grifols

The FDA has granted Grifols clearance for the Procleix Ultrio Elite, a test designed to screen for hepatitis B, hepatitis C a -More- 

Grifols: USA, Europe, JapanSales, Market Shares and Competitive Position by Product [Report Updated: 01011970] Prices from USD $1850

This unique market intelligence report from VPGMarketResearch provides information not available from any other published source. The report includes diagnostics sales and market share estimates by pr...

Grifols demonstrates a significant reduction (61%) in the progression of moderate Alzheimer's ...

BARCELONA, Spain, Oct. 27, 2018 /PRNewswire/ -- Presenting the study results, Antonio Páez, M.D., Grifols Medical Director and Head of the AMBAR Clinical Program confirmed Read more...

FTC finds Grifols’ acquisition of Biotest US is anticompetitive

Grifols is a global healthcare company based in Spain. Biotest US is a healthcare company based in Florida. According to the complaint, which was announced in August 2018, The post FTC finds Grifols&...

Grifols steigert den Nettogewinn um 15% auf 319 Mio. Euro / Nachhaltiges operatives Umsatzwachstum von 7%

Barcelona / Frankfurt (ots) - Grifols, einer der weltweit führenden Hersteller von aus Plasma gewonnenen biologischen Arzneimitteln mit Hauptsitz in Barcelona, hat die Ergebnisse für das erste Halb....

Grifols secures FTC’s conditional approval for Biotest US acquisition

Grifols is a global healthcare company based in Spain. Biotest US is a healthcare company based in Florida. According to the complaint, which was announced in August 2018, The post Grifols secures FT...

PubMed Articles [1 Associated PubMed Articles listed on BioPortfolio]

Commentary for Hepatology Elsewhere Timely administration of birth dose HBV vaccine may break the chain of perinatal transmission.

This is a multicenter, double-blind, placebo-controlled clinical trial conducted in Thailand. A total of 331 HBeAg positive pregnant women with hepatitis B infection were randomly assigned to receive ...

Clinical Trials [8 Associated Clinical Trials listed on BioPortfolio]

Safety and Efficacy Study of Fibrin Sealant Grifols Evaluated as an Adjunct to Hemostasis

The purpose of this study is to evaluate the safety and hemostasis effectiveness of human plasma-derived fibrin sealant Grifols (FS Grifols) in peripheral vascular surgery.

Safety and Efficacy of Fibrin Sealant Grifols as an Adjunct to Haemostasis During Surgery in Paediatric Subjects

This is a prospective, randomized, active-controlled, single-blind, parallel group clinical trial to evaluate the safety and efficacy of FS Grifols as an adjunct to hemostasis during surge...

Safety and Efficacy of Topical Thrombin (Human) Grifols as an Adjunct to Hemostasis During Open Surgeries

This purpose of this clinical trial is to study the safety and efficacy of Topical Thrombin (Human) Grifols as an add-on treatment to help stop bleeding during vascular, parenchymous tissu...

Clinical Trial in Patients Diagnosed With Immune Thrombocytopenic Purpura

The purpose of this study is to determine whether IGIV3I 10% Grifols is effective in the treatment of immune thrombocytopenic purpura.

IGIV Study for Chronic ITP Patients Ages 3-70

Idiopathic (immune) thrombocytopenic purpura (ITP) is an autoimmune disorder characterized by platelet destruction and thrombocytopenia (peripheral blood platelet count < 150 x 10(9)/L). ...

Companies [186 Associated Companies listed on BioPortfolio]

Aradigm Corporation and Grifols S.A.

Aradigm is an emerging specialty pharmaceutical company focused on the development and commercialization of drugs delivered by inhalation for the prevention and treatment of sever...

Grifols Biomat USA

Grifols Biomat USA is part of a large a network of plasma collection centers owned and operated by Grifols, a global healthcare company headquartered in Barcelona, Spain. Today, Grifols' plasma t...

Grifols

Grifols has been present in the field of healthcare since 1940 creating innovative products and services based on the values of ethics and responsibility. Over the decades, Grifols has contributed sig...

Grifols S.A.

Grifols S.A. is a Spain-based company in the healthcare sector involved in the research, development, manufacturing and marketing of plasma therapies, IV therapy solutions, enteral and parenteral nutr...

Grifols, Inc.

Currently, we supply plasma products, diagnostic reagents, automated analyzers and dosing machines.In 1998, Grifols established a joint venture with a US diagnostic company, Quest International. Then,...

More Information about "Aradigm Corporation and Grifols S.A." on BioPortfolio

We have published hundreds of Aradigm Corporation and Grifols S.A. news stories on BioPortfolio along with dozens of Aradigm Corporation and Grifols S.A. Clinical Trials and PubMed Articles about Aradigm Corporation and Grifols S.A. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Aradigm Corporation and Grifols S.A. Companies in our database. You can also find out about relevant Aradigm Corporation and Grifols S.A. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Respiratory
Asthma COPD Cystic Fibrosis Pneumonia Pulmonary Medicine Respiratory Respiratory tract infections (RTIs) are any infection of the sinuses, throat, airways or lungs.  They're usually caused by viruses, but they can also ...

Infectious-diseases
Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...


Corporate Database Quicklinks



Searches Linking to this Company Record